| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 6.610 | 28.190 | 43.875 | 64.081 | 80.449 | 89.714 | 103.673 | 111.755 |
| Total Income - EUR | - | - | 6.610 | 28.192 | 43.876 | 66.149 | 80.451 | 89.716 | 103.897 | 111.757 |
| Total Expenses - EUR | - | - | 11.352 | 24.967 | 37.867 | 44.378 | 50.697 | 47.930 | 47.024 | 56.395 |
| Gross Profit/Loss - EUR | - | - | -4.742 | 3.225 | 6.009 | 21.771 | 29.754 | 41.786 | 56.874 | 55.361 |
| Net Profit/Loss - EUR | - | - | -4.808 | 2.943 | 5.570 | 21.354 | 29.046 | 41.024 | 55.835 | 52.126 |
| Employees | - | - | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 1 |
Check the financial reports for the company - Royal Mossad Medical Sri Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 2.223 | 8.194 | 8.990 | 18.181 | 21.153 | 53.982 | 46.825 | 57.944 |
| Current Assets | - | - | 1.422 | 4.245 | 9.478 | 13.738 | 40.152 | 60.658 | 103.821 | 84.409 |
| Inventories | - | - | 12 | 0 | 0 | 512 | 501 | 502 | 501 | 498 |
| Receivables | - | - | 1.360 | 2.756 | 3.848 | 7.422 | 7.660 | 7.968 | 89.530 | 69.368 |
| Cash | - | - | 50 | 1.489 | 5.630 | 5.804 | 31.992 | 52.188 | 13.791 | 14.543 |
| Shareholders Funds | - | - | -4.764 | -1.850 | 3.756 | 25.039 | 53.530 | 94.415 | 138.415 | 132.585 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 8.409 | 14.289 | 14.712 | 6.880 | 7.775 | 20.225 | 12.231 | 9.767 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Royal Mossad Medical Sri Srl